Prevention of Surgical Site Contamination With Cutibacterium acnes During Cardiac Surgery: A Randomized - Summary - MDSpire

Prevention of Surgical Site Contamination With Cutibacterium acnes During Cardiac Surgery: A Randomized

  • By

  • Isabell Moter

  • Sören Schubert

  • Ana Goncalves

  • Shekhar Saha

  • Kurosh Sarbandi

  • Judith Kikhney

  • Annette Moter

  • Edgar Eszlari

  • Christian Hagl

  • Walter Eichinger

  • July 8, 2026

  • 0 min

Share

Objective:

To assess whether targeted intraoperative hygiene measures could reduce surgical site contamination with Cutibacterium acnes in male patients undergoing cardiac surgery.

Approach:
  • Study Design: A multicenter, parallel-group, randomized clinical trial conducted at a university hospital and a university-affiliated teaching hospital in Munich, Germany, from October 28, 2024, to March 3, 2025.
Key Findings:
  • Cutibacterium acnes is now recognized as a relevant pathogen in prosthetic valve endocarditis.
  • The prevalence of C acnes in PVE cases is estimated to be between 3.8% and 8.0%.
  • Current disinfection protocols may not effectively eliminate C acnes from deep within hair follicles.
Interpretation:

The study aims to determine the effectiveness of enhanced intraoperative hygiene measures in reducing C acnes contamination during cardiac surgery.

Limitations:
  • The study was limited to male patients, which may affect the generalizability of the findings.
  • The trial's duration and sample size may limit the statistical power to detect differences.
Conclusion:

The study investigates the effectiveness of enhanced hygiene practices in reducing C acnes contamination during cardiac surgery.

Original Source(s)

Related Content